pep11 market prescribed valuation on discovery, page-5

thx for the effort once again harry.
just to add something which is easily overlooked from the valuation chart is the fact that gba owns an extra 4.25% of total pep11 exposure (5% of advent energy)which represents an increase of 39% to its own pep11 exposure through its holdings in mmr and bph.


ie. on the lowest estimate for gba at $2/aud-boe on the new valuation table listed as $3.44 per share in fact increases to around $4.78 per share and fully diluted for the gba's unlisted options you get around $4.21 per share which would work out as a 7.7 bagger from yesterdays close.

happy to be shown otherwise.

ava nice day all, dcob.